Back

Association of triglyceride-glucose index and vascular aging with cardiovascular diseases in China: PURE cohort study

30 August 2025 (15:55 - 16:05)
Organised by: Logo
Congress Presentation Part of: Traditional and emerging factors driving population outcomes Epidemiology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Qiujing Cai

Fuwai Hospital, Beijing (China)

5 More presentations in this session

Presentation thumbnail
The long-term impact of traditional risk factors for atherosclerosis: analysis by sex and by arterial territory
Miss M. van den Bogaart (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Prevalence, penetrance, and coronary heart disease risk of familial hypercholesterolemia across diverse ancestries
Doctor O. Dikilitas (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Cardiovascular-kidney-liver-metabolic-health:a population-based study on the prognostic impact of the coexistence of metabolic dysfunction-associated steatotic liver disease and chronic kidney disease
Ms R. Goh (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Frailty trajectories and their associations with short and long-term clinical outcomes in patients with heart failure: an analysis of over 400,000 individuals using a primary care database in the UK.
Doctor S. Sze (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Long-term cardiovascular outcomes in patients surviving septic shock: a danish nationwide cohort study
Doctor J. Strange (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Traditional and emerging factors driving population outcomes
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 15:55 CET
You may be interested in
thumbnail
Congress Session
Metabolic drivers of cardiovascular disease
thumbnail
Congress Session
Traditional and emerging factors driving population outcomes
thumbnail
Congress Presentation
Association of dynamic changes in triglyceride-glucose index with lipid profiles and target attainments in coronary artery disease patients undergoing lipid-lowering therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources